LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Water Soluble Ball Delivers Accurate Quantitative Microbiological Control

By LabMedica International staff writers
Posted on 04 Jan 2011
Print article
Image: The bioMérieux BioBall (photo courtesy bioMérieux).
Image: The bioMérieux BioBall (photo courtesy bioMérieux).
A small, water-soluble ball containing a precise number of microorganisms, delivers unprecedented accuracy for quantitative microbiological quality control.

Dubbed BioBall, the standard ball products are derived from strains sourced from internationally recognized culture collections.

bioMérieux, (Marcy l'Etoile, France), a leader in the field of in vitro diagnostics (IVD) and in microbiological control for the biopharma and food industries, developed BioBall to provide pharmaceutic microbiology laboratories with their own isolates in a convenient, easy-to-use format.

Many pharmaceutic companies implement standard operating procedures that incorporate several representative strains from among their own bacterial and fungal isolates (from environmental monitoring, sterility, or bioburden testing). Maintaining these strains in-house is time-consuming and costly compared with the quality control (QC) strains such as BioBall that are available for routine use.

BTF (Sydney, Australia), a bioMérieux company, developed the BioBall Plant Isolate service in response to changing practices in culture media quality control for validation and routine testing. BioBall Plant Isolate will enable customers to implement best practices in media QC for their critical environmental monitoring and sterility testing.

BioBall mixed kits contain the most relevant pharmacopeia strains required for quantitative microbiology. Three different products for pharmaceutic QC are available: BioBall SingleShot, BioBall MultiShot 550, and BioBall MultiShot 10E8

BioBall SingleShot mixed kit and BioBall MultiShot 550 mixed kit contain two vials of Aspergillus brasiliensis, two vials of Bacillus subtilis, one vial of Candida albicans, one vial of Escherichia coli, two vials of Pseudomonas aeruginosa, and two vials of Staphylococcus aureus.

BioBall MultiShot 10E8 contains the same mixture of bacteria without C. albicans.

Related Links:

bioMérieux
BTF


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more